Detalles de la búsqueda
1.
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Clin Infect Dis
; 68(3): 466-474, 2019 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29945169
2.
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
Clin Infect Dis
; 69(9): 1509-1516, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30629148
3.
Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report.
Malar J
; 15: 476, 2016 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27639691
4.
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria.
Vaccines (Basel)
; 12(2)2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400149
5.
Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.
Front Immunol
; 14: 1119820, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36993981
6.
Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso.
Microorganisms
; 11(11)2023 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38004821
7.
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Front Immunol
; 14: 1267372, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37908361
8.
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
Front Cell Infect Microbiol
; 12: 1058081, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36590593
9.
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Front Immunol
; 13: 978591, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36119062
10.
Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency.
Hum Vaccin
; 7(9): 913-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21892006
11.
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses.
NPJ Vaccines
; 6(1): 55, 2021 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33854065
12.
Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine.
Kidney Int
; 77(3): 247-55, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19940840
13.
Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults.
Hum Vaccin
; 6(7): 578-84, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20523113
14.
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Front Immunol
; 11: 412, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32210975
15.
Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool.
F1000Res
; 8: 1066, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32148758
16.
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRß clonotypes.
J Exp Med
; 216(8): 1857-1873, 2019 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31175140
17.
Workshop report: Experimental animal models for universal influenza vaccines.
Vaccine
; 36(46): 6895-6901, 2018 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30340885
18.
Workshop report: Immunoassay standardisation for "universal" influenza vaccines.
Influenza Other Respir Viruses
; 11(3): 194-201, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28146323
19.
Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation.
PLoS One
; 11(10): e0164053, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27695087
20.
The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
PLoS One
; 10(9): e0135406, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26327283